PAYX
54
-3
R
75
-2
XRX
37
3
QCOM
57
2
STI
21
-10
AVGO
30
-5
FAST
61
-3
SE
57
-3
AAP
44
2
CSCO
61
-6
ZBH
62
-3
TGT
50
-2
NWL
50
-6
HBI
56
-2
EQR
53
-7
HOG
35
2
NI
70
-3
LH
46
-4
LMT
34
-5
DVN
21
-8
PAYX
54
-3
R
75
-2
XRX
37
3
QCOM
57
2
STI
21
-10
AVGO
30
-5
FAST
61
-3
SE
57
-3
AAP
44
2
CSCO
61
-6
ZBH
62
-3
TGT
50
-2
NWL
50
-6
HBI
56
-2
EQR
53
-7
HOG
35
2
NI
70
-3
LH
46
-4
LMT
34
-5
DVN
21
-8
Financhill
Back

SpringWorks Therapeutics Quote, Financials, Valuation and Earnings

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.
Buy
64

SWTX
SpringWorks Therapeutics

Last Price:
35.55
Seasonality Move:
54.9%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

SpringWorks Therapeutics Price Quote

$35.55
-1.00 (-2.74%)
(Updated: November 15, 2024 at 10:55 AM ET)

SpringWorks Therapeutics Key Stats

Buy
64
SpringWorks Therapeutics (SWTX) is a Buy
Day range:
$34.20 - $36.78
52-week range:
$19.61 - $53.92
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.88%
Volume:
2.1M
Avg. volume:
1.1M
1-year change:
64.12%
Market cap:
$2.7B
Revenue:
$5.4M
EPS:
$-4.44

How Much Does SpringWorks Therapeutics Make?

Data Unavailable

Is SpringWorks Therapeutics Growing As A Company?

Data Unavailable

SpringWorks Therapeutics Stock Price Performance

What Is SpringWorks Therapeutics 52-Week High & Low?

SpringWorks Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy SpringWorks Therapeutics?

Is SpringWorks Therapeutics Cash Flow Positive?

  • What Is SWTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$233.9M
  • What Is SpringWorks Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $301.6M
  • What Is SpringWorks Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$102.9M

SpringWorks Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    SWTX return on invested capital is -57.97%
  • What Is SpringWorks Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -50.43%
  • What Is SWTX Return On Equity?
    ROE is a measure of profitability and is -57.97%

SpringWorks Therapeutics Earnings Date & Stock Price

SpringWorks Therapeutics Competitors

SpringWorks Therapeutics Dividend Yield

SpringWorks Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 5.26%
Revenue: 0% -10.59%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 68.00
Upside from Last Price: 86.05%

Major Shareholders

  • How many SWTX shares are owned by institutional investors?
    134.1M SWTX shares are owned by institutional investors
  • How many SWTX shares are owned by insiders?
    2.9M SWTX shares are owned by insiders